Introduction: This study aimed to clarify whether 1 year of vitamin D3 supplementation has a direct effect on body composition and physical fitness in healthy adults. Methods: Ninety-five participants randomly received either 420 IU vitamin D3 per day (n = 48) or placebo (n = 47) in a double-blind manner for 1 year. Lean body mass and percentage body fat were determined. Physical fitness including hand grip strength, leg extension power and cardiorespiratory fitness (CRF) were assessed. Serum 25-hydroxyvitamin D (25[OH]D) and 1,25-dihydroxyvitamin D (1,25[OH]2D) concentrations were assessed using ELISA kits. Results: Serum 25(OH)D and (1,25[OH]2D) concentrations significantly increased by approximately 11.2 ± 9.2 ng/mL (pinteraction <0.001)and 7.0 ± 7.8 pg/mL (pinteraction <0.001) after 1 year of vitamin D3 supplementation respectively. Lean body mass significantly increased from 43.8 ± 9.6 to 44.3 ± 9.8 kg in vitamin D group, while no change was observed in placebo group (from 42.6 ± 8.9 to 42.4± 8.9 kg) after 1 year intervention. Furthermore, no treatment effects on other indicators of body composition and physical fitness were observed. Conclusions: One year of vitamin D supplementation effectively improves lean body mass, but not muscle strength and CRF in healthy adults.

Keywords:
25-Hydroxyvitamin D, Body fat, Lean body mass, Cardiorespiratory fitness, Hand grip strength
1.
Wacker M, Holick MF. Vitamin D – effects on skeletal and extraskeletal health and the need for supplementation.
Nutrients
. 2013 Jan;5(1):111–48.
2.
Holick MF. High prevalence of vitamin D inadequacy and implications for health.
Mayo Clin Proc
. 2006 Mar;81(3):353–73.
3.
Farrell SW, Fitzgerald SJ, McAuley PA, Barlow CE. Cardiorespiratory fitness, adiposity, and all-cause mortality in women.
Med Sci Sports Exerc
. 2010 Nov;42(11):2006–12.
4.
Rantanen T. Muscle strength, disability and mortality.
Scand J Med Sci Sports
. 2003 Feb;13(1):3–8.
5.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.
J Clin Invest
. 2002 Jul;110(2):229–38.
6.
Mitsuhashi T, Morris RC Jr, Ives HE. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.
J Clin Invest
. 1991 Jun;87(6):1889–95.
7.
Ardestani A, Parker B, Mathur S, Clarkson P, Pescatello LS, Hoffman HJ, et al. Relation of vitamin D level to maximal oxygen uptake in adults.
Am J Cardiol
. 2011 Apr;107(8):1246–9.
8.
Ellis AC, Alvarez JA, Gower BA, Hunter GR. Cardiorespiratory fitness in older adult women: relationships with serum 25-hydroxyvitamin D.
Endocrine
. 2014 Dec;47(3):839–44.
9.
Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J, et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials.
J Clin Endocrinol Metab
. 2014 Nov;99(11):4336–45.
10.
Karefylakis C, Särnblad S, Ariander A, Ehlersson G, Rask E, Rask P. Effect of vitamin D supplementation on body composition and cardiorespiratory fitness in overweight men-a randomized controlled trial.
Endocrine
. 2018 Sep;61(3):388–97.
11.
Singla M, Rastogi A, Aggarwal AN, Bhat OM, Badal D, Bhansali A. Vitamin D supplementation improves simvastatin-mediated decline in exercise performance: A randomized double-blind placebo-controlled study.
J Diabetes
. 2017 Dec;9(12):1100–6.
12.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity.
Am J Clin Nutr
. 2000 Sep;72(3):690–3.
13.
Sulistyoningrum DC, Green TJ, Lear SA, Devlin AM. Ethnic-specific differences in vitamin D status is associated with adiposity.
PLoS One
. 2012;7(8):e43159.
14.
Sun X, Cao ZB, Tanisawa K, Ito T, Oshima S, Ishimi Y, et al. Associations between the serum 25(OH)D concentration and lipid profiles in Japanese men.
J Atheroscler Thromb
. 2015;22(4):355–62.
15.
Song Q, Sergeev IN. Calcium and vitamin D in obesity.
Nutr Res Rev
. 2012 Jun;25(1):130–41.
16.
Mai XM, Chen Y, Camargo CA Jr, Langhammer A. Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study.
Am J Epidemiol
. 2012 May;175(10):1029–36.
17.
Wamberg L, Kampmann U, Stødkilde-Jørgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels – results from a randomized trial.
Eur J Intern Med
. 2013 Oct;24(7):644–9.
18.
Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, Dehghani S, et al. A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women.
Nutr J
. 2012 Sep;11(1):78.
19.
Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, et al. Epidemic obesity and type 2 diabetes in Asia.
Lancet
. 2006 Nov;368(9548):1681–8.
20.
Sun X, Cao ZB, Tanisawa K, Ito T, Oshima S, Higuchi M. Vitamin D supplementation reduces insulin resistance in Japanese adults: a secondary analysis of a double-blind, randomized, placebo-controlled trial.
Nutr Res
. 2016 Oct;36(10):1121–9.
21.
Cao ZB, Miyatake N, Higuchi M, Miyachi M, Tabata I. Predicting VO(2max) with an objectively measured physical activity in Japanese men.
Eur J Appl Physiol
. 2010 Jun;109(3):465–72.
22.
Murakami K, Livingstone MB, Sasaki S. Diet quality scores in relation to metabolic risk factors in Japanese adults: a cross-sectional analysis from the 2012 National Health and Nutrition Survey, Japan.
Eur J Nutr
. 2019 Aug;58(5):2037–50.
23.
Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men.
Osteoporos Int
. 1998;8(3):222–30.
24.
Zhang L, Quan M, Cao ZB. Effect of vitamin D supplementation on upper and lower limb muscle strength and muscle power in athletes: A meta-analysis.
PLoS One
. 2019 Apr;14(4):e0215826.
25.
Lang JJ, Wolfe Phillips E, Orpana HM, Tremblay MS, Ross R, Ortega FB, et al. Field-based measurement of cardiorespiratory fitness to evaluate physical activity interventions.
Bull World Health Organ
. 2018 Nov;96(11):794–6.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.